ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

BPMC Blueprint Medicines Corporation

105,55
-0,84 (-0,79%)
14 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Blueprint Medicines Corporation BPMC NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,84 -0,79% 105,55 17:24:26
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
104,44 103,49 106,855 105,55 106,39
mais cotações »

Notícias Recentes

Data Hora Fonte Título
30/05/202419:01PRNUSBlueprint Medicines Announces Data Presentations at EAACI..
23/05/202418:05PRNUSBlueprint Medicines to Present the First Promising and Most..
06/05/202417:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
02/05/202408:00PRNUSBlueprint Medicines Reports Strong First Quarter 2024..
18/04/202409:00PRNUSBlueprint Medicines to Report First Quarter 2024 Financial..
11/04/202409:00PRNUSBlueprint Medicines to Host Webcast and Conference Call..
04/04/202417:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
06/03/202418:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
23/02/202410:00PRNUSBlueprint Medicines Highlights AYVAKIT® (avapritinib)..
15/02/202409:00PRNUSBlueprint Medicines Reports Fourth Quarter and Full Year..
05/02/202418:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
01/02/202410:00PRNUSBlueprint Medicines to Report Fourth Quarter and Full Year..
08/01/202410:00PRNUSBlueprint Medicines Highlights 2024 Corporate Strategy and..
05/01/202418:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
18/12/202310:00PRNUSBlueprint Medicines to Present at 42nd Annual J.P. Morgan..
12/12/202310:05PRNUSBlueprint Medicines' AYVAKYT® (avapritinib) Receives..
09/12/202314:30PRNUSBlueprint Medicines' Leadership in Driving Continued..
04/12/202318:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
28/11/202310:00PRNUSBlueprint Medicines to Present at JMP Securities Hematology..
10/11/202310:00PRNUSBlueprint Medicines' AYVAKYT® (avapritinib) Receives..
03/11/202317:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
26/10/202308:00PRNUSBlueprint Medicines Reports Third Quarter 2023 Results
23/10/202309:30PRNUSAnixa Biosciences Appoints Accomplished Medical Oncologist..
12/10/202309:00PRNUSBlueprint Medicines to Report Third Quarter 2023 Financial..
05/10/202317:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
05/09/202317:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
04/08/202317:16PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
02/08/202308:00PRNUSBlueprint Medicines Reports Second Quarter 2023 Results
19/07/202309:00PRNUSBlueprint Medicines to Report Second Quarter 2023 Financial..
05/07/202317:30PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..